The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review
نویسندگان
چکیده
OBJECTIVES To review studies on the cost consequences of compliance and/or persistence in cardiovascular disease (CVD) and related conditions (hypertension, dyslipidaemia, diabetes and heart failure) published since 1995, and to evaluate the effects of noncompliance on healthcare expenditure and the cost-effectiveness of pharmaceutical interventions. METHODS English language papers published between January 1995 and February 2007 that examined compliance/persistence with medication for CVD or related conditions, provided an economic evaluation of pharmacological interventions or cost analysis, and quantified the cost consequences of noncompliance, were identified through database searches. The cost consequences of noncompliance were compared across studies descriptively. RESULTS Of the 23 studies identified, 10 focused on hypertension, seven on diabetes, one on dyslipidaemia, one on coronary heart disease, one on heart failure and three covered multiple diseases. In studies assessing drug costs only, increased compliance/persistence led to increased drug costs. However, increased compliance/persistence increased the effectiveness of treatment, leading to a decrease in medical events and non-drug costs. This offset the higher drug costs, leading to savings in overall treatment costs. In studies evaluating the effect of compliance/persistence on the cost-effectiveness of pharmacological interventions, increased compliance/persistence appeared to reduce cost-effectiveness ratios, but the extent of this effect was not quantified. CONCLUSIONS Noncompliance with cardiovascular and antidiabetic medication is a significant problem. Increased compliance/persistence leads to increased drug costs, but these are offset by reduced non-drug costs, leading to overall cost savings. The effect of noncompliance on the cost-effectiveness of pharmacological interventions is inconclusive and further research is needed to resolve the issue.
منابع مشابه
Sociological Analysis of the Behavioral Style and Economic Status of Cardiovascular Desease Patientsin in Javad Al-Aemeh Heart Hospital of Mashhad
Introduction: This is a sociological study of the economic burden on patients writh cardiovascular disease (CVD) based on the behavior change approach in their behavior in Javad Al-Aeme hospital of Mashhad in 2020. Method: This is a cross-sectional survey conducted on a population of 385 CVD patients of over 50 years of age admitted to the Training, Research and Treatment Center of Javad Al-Ae...
متن کاملSociological Analysis of the Behavioral Style and Economic Status of Cardiovascular Desease Patientsin in Javad Al-Aemeh Heart Hospital of Mashhad
Introduction: This is a sociological study of the economic burden on patients writh cardiovascular disease (CVD) based on the behavior change approach in their behavior in Javad Al-Aeme hospital of Mashhad in 2020. Method: This is a cross-sectional survey conducted on a population of 385 CVD patients of over 50 years of age admitted to the Training, Research and Treatment Center of Javad Al-Ae...
متن کاملPre-travel Health Advice for Patients With Cardiovascular Disease
Cardiovascular disease (CVD) is the leading cause of death among international travellers. Practitioner knowledge of the effects of CVD on international travel is imperative in order to promote a healthy travel experience. This review aimed to explore the available literature on this topic. The PubMed database was accessed to source relevant literature using combinations of relevant keywords as...
متن کاملEstimation of the Economic Burden of Cardiovascular Diseases in selected Hospital of Mashhad in 2020 Javadalameh Heart Hospital)
In Iran, cardiovascular diseases rank first in terms of mortality. Cardiovascular disease leads families to fall into the abyss of poverty and worsens the disease. Health policy makers need to be aware of the costs of these diseases in order to make decisions about the optimal allocation of resources. The aim of this study was to estimate the economic burden of cardiovascular diseases in select...
متن کاملTaking Renin-Angiotensin Drugs in Patients with COVID-19: Start, Continue, or Stop; a Literature Review
Considering the pandemic of the COVID-19 disease, the use of various drugs in patients has been investigated. Recently, numerous studies have been done on the effectiveness of drugs which used to treat the underlying disease such as congestive heart failure, hypertension, as well as coronary artery disease in various countries, because the patients with underlying conditions are more likely ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- International Journal of Clinical Practice
دوره 62 شماره
صفحات -
تاریخ انتشار 2008